| pubmed-article:11014350 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11014350 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:11014350 | lifeskim:mentions | umls-concept:C0043157 | lld:lifeskim |
| pubmed-article:11014350 | lifeskim:mentions | umls-concept:C1258104 | lld:lifeskim |
| pubmed-article:11014350 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:11014350 | lifeskim:mentions | umls-concept:C0965912 | lld:lifeskim |
| pubmed-article:11014350 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11014350 | pubmed:dateCreated | 2000-10-19 | lld:pubmed |
| pubmed-article:11014350 | pubmed:abstractText | Systemic sclerosis (SSc) is uncommon in men, and relatively little is known about factors contributing to its pathogenesis in this population. In the current study, we investigated HLA class II alleles in men with SSc. We also investigated the hypothesis that HLA compatibility of the mother could be a risk factor for SSc in men. | lld:pubmed |
| pubmed-article:11014350 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11014350 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11014350 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11014350 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11014350 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11014350 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:FurstD EDE | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:NelsonJ LJL | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:Müller-Ladner... | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:DistlerOO | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:LambertN CNC | lld:pubmed |
| pubmed-article:11014350 | pubmed:author | pubmed-author:TyleeT STS | lld:pubmed |
| pubmed-article:11014350 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11014350 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:11014350 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11014350 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11014350 | pubmed:pagination | 2005-10 | lld:pubmed |
| pubmed-article:11014350 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:meshHeading | pubmed-meshheading:11014350... | lld:pubmed |
| pubmed-article:11014350 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11014350 | pubmed:articleTitle | HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. | lld:pubmed |
| pubmed-article:11014350 | pubmed:affiliation | Immunogenetics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. | lld:pubmed |
| pubmed-article:11014350 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11014350 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11014350 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:3117 | entrezgene:pubmed | pubmed-article:11014350 | lld:entrezgene |
| entrez-gene:3123 | entrezgene:pubmed | pubmed-article:11014350 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11014350 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11014350 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11014350 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11014350 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11014350 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11014350 | lld:pubmed |
